A new polymorph of 2-thiohydantoin
A new polymorphic crystal of the title compound, C3H4N2OS, belongs to space group P1 with cell dimensions of a = 4.0520(9)Å, b = 6.550(1)Å, c = 9.170(2)Å, a = 100.148(4)°, b = 100.814(4)°, g = 96.831(4)°, R1= 0.069. Neighboring molecules are connected to form cyclic dimers via two types of hydrogen bonds, one between the thioamide groups and the other ...
openaire +1 more source
Quality of Life and Psychological Factors in Patients with Metastatic Prostate Cancer Receiving Androgen Receptor-Targeted Therapies: A Prospective Cross-Sectional Real-World Study. [PDF]
Çelik S +5 more
europepmc +1 more source
Integral Lipophilicity Studies with in Silico ADMET Parameter Analysis of Novel Pseudothiohydantoin Derivatives. [PDF]
Baumgart S +3 more
europepmc +1 more source
Arylsulfonylation of 5, 5-Disubstituted 2-Thiohydantoins
A, Kobayashi, S, Umemoto, A, Kagemoto
openaire +3 more sources
Clinical Impact of Gleason Pattern 5 on Doublet Versus Triplet Therapy in Metastatic Hormone-Sensitive Prostate Cancer. [PDF]
Fujimoto S +14 more
europepmc +1 more source
Apalutamide treatment and refractory hypothyroidism: effects of apalutamide on levothyroxine metabolism. [PDF]
Quattrochi F, Grunenwald S, Caron P.
europepmc +1 more source
Synthesis and evaluation of novel thiohydantoin derivatives for antidiabetic activity using in silico in vitro and in vivo methods. [PDF]
Bukhari A +5 more
europepmc +1 more source
Comparative fall risk of patients treated with novel androgen receptor antagonists in prostate cancer: a systematic review and meta-analysis. [PDF]
Wei C +5 more
europepmc +1 more source
Reactions of Nitrile Imines with Thiohydantoin Derivatives: Unexpected Chemoselectivity of the 1,3-Dipolar Cycloaddition: Preferential Addition of C=C rather than C=S Bonds. [PDF]
Filkina ME +6 more
europepmc +1 more source
Plain language review: the safety of relugolix combination therapy for advanced prostate cancer. [PDF]
La Cerda J +6 more
europepmc +1 more source

